GLP-1 Agonists Archives - Financial Business Times

GLP-1 agonists such as Ozempic and Mounjaro have surged in popularity due to their effectiveness in managing diabetes and obesity. However, recent legal challenges highlight…

Business News

Donald Trump’s Policy Proposals Stir US Federal Reserve Concerns – Financial Business Times

Donald Trump’s anticipated return to the White House has begun to impact the US Federal Reserve’s outlook. Uncertainty surrounding his policy proposals has raised concerns...

Starbucks Faces Intensifying Union Strikes Amid Wage Disputes – Financial Business Times

A union representing over 10,000 Starbucks baristas has begun striking in Los Angeles, Chicago, and Seattle. The five-day strike, starting December 20, aims to pressure...

Federal Reserve’s Interest Rate Cut Signals Cautious Policy Shift – Financial Business Times

The Federal Reserve announced another interest rate cut on Wednesday, indicating a shift to a more cautious approach in its monetary policy. The central bank...

UK Inflation Reaches Highest Rate Since March Amid Economic Challenges – Financial Business Times

The UK’s inflation rate has reached its highest level since March, marking a significant economic challenge. The Consumer Prices Index (CPI) rose by 2.6% in...

Elon Musk’s Expanding Influence in Politics and Business – Financial Business Times

Elon Musk’s influence has reached new heights, intertwining politics and business in unprecedented ways. Known for revolutionary ventures like Tesla and SpaceX, Musk has now...

Posts tagged as “GLP-1 Agonists”

The Rising Legal Challenges Facing GLP-1 Agonists